Comparison of Frontline Therapies in Older Adults Age ≥ 80 Years With Chronic Lymphocytic Leukemia (CLL): A Mayo Clinic and Danish Nation‐Wide Study

Documenti analoghi

• The role of imaging studies in predicting time to first treatment and overall survival in high‐count monoclonal B‐cell lymphocytosis
  di: Samuel Kosydar, et al.
  Pubblicazione: (2025)
• Polypharmacy independently predicts survival, hospitalization, and infections in patients with lymphoid cancer
  di: Christian Brieghel, et al.
  Pubblicazione: (2025)
• Clonal dynamics of Richter transformation in chronic lymphocytic leukemia
  di: Hanyin Wang, et al.
  Pubblicazione: (2024)
• Medical history and lifestyle factors have limited impact on time‐to‐first‐treatment in patients with chronic lymphocytic leukemia
  di: Ingrid Glimelius, et al.
  Pubblicazione: (2024)
• Mortality in patients with lymphoid malignancies and multiple myeloma was stable upon and during the COVID‐19 pandemic: A population‐based, nation‐wide study
  di: Tereza Faitová, et al.
  Pubblicazione: (2024)